Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
O. Moldovan, D. Homorodean, E. Ibraim, M. Bendorf, C. Popa (Bucharest, Romania). The results of drug resistance survey of MDR-strains on second line drugs obtains in national reference laboratory – " M.Nasta " Institute – Bucharest. Eur Respir J 2011; 38: Suppl. 55, 2611

Member's Comments

No comment yet.

Related content which might interest you: Documentation & accuracy of smoking status – An educational need? Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders Year: 2011 Patients‘ knowledge about inhalation therapy in pulmology – One year after intervention Source: Annual Congress 2011 - Medical education Year: 2011 Usability evaluation of NEXThaler® versus Diskus® and Turbuhaler® Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 Tuberculosis – is there anything different over a decade? Source: Annual Congress 2009 - Socio-economic impact of tuberculosis Year: 2009 Airway resistances: Raw, sRaw, sReff – Which is the best determinant of airway function? Source: Annual Congress 2010 - Lung function from infancy to adulthood Year: 2010 T spot TB reactivity – ²to treat or not to treat² Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Evaluation of difficult asthma – a single centre experience Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Reorganisation of the tuberculosis laboratory network in Serbia – the lesson we learned Source: Annual Congress 2009 - Tuberculosis control Year: 2009 Allergy to Cupressus sempervirens and Juniperus communis in "Maremma" Tuscany, Italy Source: Annual Congress 2010 - Clinical aspects of asthma and allergic respiratory diseases Year: 2010 Clinical significance of Mycobacterium lentiflavum – An emerging pathogen found in potable water Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis Year: 2010 Drug interaction in tuberculosis treatment – The role of pharmacists Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Nutritional risk screening 2002 – Application in pneumology Source: Annual Congress 2012 - New insights in the clinical management of lung diseases Year: 2012 Homeless tuberculosis – our three year experiences in Bydgoszcz, Poland Source: Annual Congress 2009 - Socio-economic impact of tuberculosis Year: 2009 Patient assessments of ease of use of Genuair® versus Aerolizer® and HandiHaler® Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011 Regional reference centre for multi-drug resistant tuberculosis – 11 months of activity Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010 LungPoint® – A new approach to peripheral lung lesions Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy Year: 2010 Tackling tuberculosis among hard to reach groups in London – The Find&Treat experience Source: Annual Congress 2010 - Tuberculosis control Year: 2010 Side effects at second line TB drugs – 2 years experience of multidrug-resistant tuberculosis department from Bucharest Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010 Smoking assessment & treatment in hospital: Are we providing ‘right care‘ and/or missing cannabis-smoking? Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011 Clinical pattern of extrapulmonary tuberculosis (EPT) as observed at a teaching hospital in India – are we missing them? Source: Annual Congress 2009 - Pulmonary infections Year: 2009